Filling the need for trusted information on national health issues…

Trending on kff Medicare & Medicaid at 50 Individual Market Medicaid Expansion

Kaiser Daily Global Health Policy ReportPrograms, Funding & Financing Search Results « » The Henry J. Kaiser Family Foundation

Programs, Funding & Financing

  • your selections
Clear Search

Filter Results

date

Tags

  • results
EU Countries Should Pool Funding To Create ‘Prize’ For Bringing New Antibiotics To Market, Report Says

“European policy makers were urged Wednesday to find viable financial incentives to get drug companies to discover new antibiotics, because the lack of fresh supplies poses acute dangers to health care and efforts against infectious diseases,” according to a report by the Office of Health Economics and funded by GlaxoSmithKline, Dow Jones/Wall Street Journal reports.

Federal Appeals Court Rules Government Cannot Force Health Groups To Take Anti-Prostitution Pledge

“A federal appeals court has ruled that the United States cannot force partners in its international fight against AIDS to denounce prostitution as a condition for receiving funding,” the Associated Press reports. Three health organizations sued the government in 2005, saying some groups “advocate for a reduction in penalties for prostitution to prevent interference with outreach efforts,” according to the news agency (7/6).

Antibiotic Resistance Is Not A Priority In The U.S.

Author and journalist Maryn McKenna in her “Superbug” blog on Wired.com examines U.S. spending on drug-resistant pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). She examines data presented by Eli Perencevich of the University of Iowa and colleagues at the World HAI Forum, which looked at how much of the National Institute of Allergy and Infectious Diseases’ budget went to the problem of drug-resistant diseases versus other infectious diseases. “They found the answer to be: Not very much,” she writes.

Washington Post Examines Increase In Number Of USAID Contract Suspensions

“The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts,” the Washington Post reports in an article focusing on the agency’s suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development (AED).

India Must Not Become Complacent Despite AIDS Control Program’s Success, Prime Minister Says

“India’s Prime Minister Manmohan Singh on Monday hailed the country’s success in slashing new HIV/AIDS infections by half in the past decade, but warned against complacency,” Agence France-Presse reports. Speaking at a conference on AIDS in New Delhi, Singh said the country’s HIV prevention program “can justifiably claim a measure of success,” but “there should be no room for complacency,” as an estimated 2.4 million Indians are living with the disease, according to AFP.

Donor Fatigue Harming Efforts To Fight Drought In Horn Of Africa, Aid Agencies Say

As a severe drought affecting Somalia, Kenya, Djibouti and Ethiopia forces more people into refugee camps, donor fatigue is harming aid agencies’ abilities to work in the Horn of Africa, because “these recurrent droughts used to happen every 5-10 years but what we see now is it basically every other year … an indication of climate change conditions,” Michael Klaus, UNICEF spokesperson for east and southern Africa, told Reuters in an interview (Gachenge, 7/2).

Global Health Funding Should Not Create ‘Winners’ And ‘Losers’

Andrew Harmer, a research fellow at the London School of Hygiene and Tropical Medicine, in this globalhealthpolicy.net blog post lays out the global health “winners” and “losers” in terms of funding. “Two things will help secure future funds: show donors that what they fund delivers results, and make it clear…

Science Should Inform Global AIDS Policy

Thirty years have passed since the first reported case of AIDS, and “we now have an unprecedented opportunity, based on solid scientific data, to control and ultimately end the AIDS pandemic,” after decades of the idea being “a distant aspiration because we lacked sufficient evidence-based tools to convert the hope to reality,” Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, writes in a Science editorial.